Cita APA

Teng, C., Hwang, W., Chen, Y., Chang, K., & Cheng, S. (2012). Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: A case control study. BioMed Central.

Citación estilo Chicago

Teng, Chieh-Lin, Wen-Li Hwang, Yi-Ju Chen, Kuang-Hsi Chang, y Shao-Bin Cheng. Sorafenib for Hepatocellular Carcinoma Patients Beyond Milan Criteria After Orthotopic Liver Transplantation: A Case Control Study. BioMed Central, 2012.

Cita MLA

Teng, Chieh-Lin, et al. Sorafenib for Hepatocellular Carcinoma Patients Beyond Milan Criteria After Orthotopic Liver Transplantation: A Case Control Study. BioMed Central, 2012.